If you have a peanut allergy, it looks like there's some life changing news for you!
The first-ever drug to treat peanut allergies is on its way.
According to the Food Allergy Research & Education (FARE), peanuts are one of the top food allergies in the country.
Well, a new clinical trial is showing promising results among those tested, giving hope to peanut-allergic individuals everywhere.
Aimmune Therapeutics, a biotech company in the US, conducted a year-long clinical trial in which they administered daily capsules of their peanut flour to 500 children and teens.
By the end of the year, they found that 67 percent of the participants were able to tolerate 660 mg of peanut protein (about two nuts), as compared to the 4 percent of participants on a placebo powder.
But that doesn't mean you should go try it for yourself because even in the controlled trial some children faced adverse reactions that caused them to drop of the study.
From the results, the drug wouldn't allow you to eat a peanut butter and jelly sandwich, but it would help reduce a life-threatening reaction if they're exposed to peanuts.
Aimmune is hoping for FDA approval later this year, and is likely to cost $5,000 to $10,000 for the first six months of treatment.
Then it will be $400 a month after that.